Search
for
Sort by
Research 61–90 of 1000+
- The clinical applications of five-alpha reductase inhibitors.
- Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model
- Post-finasteride syndrome: survey of dermatologists from the Spanish Hair and Nail Disorders Group
- PD49-02 MEDICATIONS MOST COMMONLY ASSOCIATED WITH ERECTILE DYSFUNCTION: EVALUATION OF THE FOOD AND DRUG ADMINISTRATION NATIONAL PHARMACOVIGILANCE DATABASE
- Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial
- Editorial Comment
- Post-Finasteride Syndrome (PFS) Update: Point/Counterpoint
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- Effects of 5-alpha reductase inhibitors
- Finasteride versus dutasteride: a real-world economic evaluation.
- MP44-04 TRENDS IN 5-ALPHA REDUCTASE INHIBITOR USE BEFORE AND AFTER THE FOOD AND DRUG ADMINISTRATION SAFETY WARNING
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Common urologic diseases in older men and their treatment: how they impact fertility
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Male pattern hair loss: Can developmental origins explain the pattern?
- Male-pattern hair loss: Comprehensive identification of the associated genes as a basis for understanding pathophysiology
- Association of Suicidality and Depression With 5α-Reductase Inhibitors
- 5-Alpha Reductase Inhibitors and Erectile Dysfunction: The Connection
- Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis
- Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- 5α-Reductase inhibitors in androgenetic alopecia
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?